650
Participants
Start Date
May 28, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Cytisinicline
film-coated oral tablets containing 3 mg cytisinicline
Rochester Clinical Research, LLC, Rochester
Altoona Center for Clinical Research, Duncansville
Alliance for Multispecialty Research, LLC, Norfolk
Health Research of Hampton Roads, Inc., Newport News
Coastal Carolina Research Center, North Charleston
Clinical Research Atlanta, Stockbridge
Jacksonville Center for Clinical Research, Jacksonville
Accel Research Sites Network - DeLand Clinical Research Unit, DeLand
Alliance for Multispecialty Research, LLC, Coral Gables
Precision Clinical Research, Sunrise
Alliance for Multispecialty Research, LLC, Fort Myers
Alliance for Multispecialty Research, LLC, Mobile
Clinical Research Associates, Inc., Nashville
Alliance for Multispecialty Research, LLC, Knoxville
Alliance for Multispecialty Research, LLC, Lexington
Centricity Research Columbus Ohio Multispecialty, Columbus
MediSphere Medical Research Center, LLC, Evansville
Insight Research Institute, Flint
Alliance for Multispecialty Research, LLC, Oak Brook
Alliance for Multispecialty Research, LLC, Kansas City
Alliance for Multispecialty Research, LLC, Wichita
Alliance for Multispecialty Research, LLC, New Orleans
Little Rock Allergy & Asthma Clinical Research Center, Little Rock
Alliance for Multispecialty Research, LLC, Norman
Clinical Trials of Texas, LLC, San Antonio
Alliance for Multispecialty Research, LLC, Tempe
Alliance for Multispecialty Research, LLC, Las Vegas
Massachusetts General Hospital - Clinical Genetic Facility, Boston
Global Medical Institutes LLC; Princeton Medical Institute, Princeton
Lead Sponsor
Achieve Life Sciences
INDUSTRY